{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:04:35Z","timestamp":1792537475937,"version":"4.5.0"},"reference-count":38,"publisher":"American Society of Hematology","issue":"1","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The inherited bone marrow failure syndromes are traditionally considered to be pediatric disorders, but in fact, many of the patients now are diagnosed as adults, and many diagnosed as children now live to reach adulthood. The most common of these rare disorders include Fanconi anemia, dyskeratosis congenita, Shwachman-Diamond syndrome and amegakaryocytic thrombocytopenia, which often develop aplastic anemia and may evolve into myelodysplastic syndrome and acute myeloid leukemia; and Diamond-Blackfan anemia, severe congenital neutropenia, and thrombocytopenia absent radii, single cytopenias that rarely if ever become aplastic but have increased risks of leukemia. In addition, the first three syndromes have high risks of solid tumors: head and neck and anogenital squamous cell carcinoma in Fanconi anemia and dyskeratosis congenita, and osteogenic sarcoma in Diamond-Blackfan anemia. Diagnosis of a marrow failure syndrome requires recognition of characteristic physical abnormalities when present, and consideration of these disorders in the differential diagnosis of patients who present with \u201cacquired\u201d aplastic anemia, myelodysplastic syndrome, acute myeloid leukemia, or atypically early cancers of the types seen in the syndromes. Ultimate proof will come from identification of pathogenic mutations in genes associated with each syndrome.<\/jats:p>","DOI":"10.1182\/asheducation-2007.1.29","type":"journal-article","created":{"date-parts":[[2007,11,16]],"date-time":"2007-11-16T13:08:40Z","timestamp":1195218520000},"page":"29-39","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":169,"title":["Diagnosis, Genetics, and Management of Inherited Bone Marrow Failure Syndromes"],"prefix":"10.1182","volume":"2007","author":[{"given":"Blanche P.","family":"Alter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111702525579800_R1","doi-asserted-by":"crossref","unstructured":"Bagby GC, Alter BP. Fanconi anemia. Semin Hematol. 2006;43:147\u2013156.","DOI":"10.1053\/j.seminhematol.2006.04.005"},{"key":"2019111702525579800_R2","doi-asserted-by":"crossref","unstructured":"Kutler DI, Singh B, Satagopan J, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood. 2003;101:1249\u20131256.","DOI":"10.1182\/blood-2002-07-2170"},{"key":"2019111702525579800_R3","doi-asserted-by":"crossref","unstructured":"Dokal I. Dyskeratosis congenita in all its forms. Br J Haematol. 2000;110:768\u2013779.","DOI":"10.1046\/j.1365-2141.2000.02109.x"},{"key":"2019111702525579800_R4","doi-asserted-by":"crossref","unstructured":"Vulliamy T, Dokal I. Dyskeratosis congenita. Semin Hematol. 2006;43:157\u2013166.","DOI":"10.1053\/j.seminhematol.2006.04.001"},{"key":"2019111702525579800_R5","doi-asserted-by":"crossref","unstructured":"Rosenberg PS, Alter BP, Bolyard AA, et al. The incidence of leukemia and mortality from sepsis in patients with severe congenital neutropenia receiving long-term G-CSF therapy. Blood. 2006;107:4628\u20134635.","DOI":"10.1182\/blood-2005-11-4370"},{"key":"2019111702525579800_R6","doi-asserted-by":"crossref","unstructured":"Lipton JM, Atsidaftos E, Zyskind I, Vlachos A. Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry. Pediatr Blood Cancer. 2006;46:558\u2013564.","DOI":"10.1002\/pbc.20642"},{"key":"2019111702525579800_R7","doi-asserted-by":"crossref","unstructured":"Rothbaum R, Perrault J, Vlachos A, et al. Shwachman-Diamond syndrome: report from an international conference. J Pediatr. 2002;141:266\u2013270.","DOI":"10.1067\/mpd.2002.125850"},{"key":"2019111702525579800_R8","doi-asserted-by":"crossref","unstructured":"Rosenberg PS, Greene MH, Alter BP. Cancer incidence in persons with Fanconi anemia. Blood. 2003;101:822\u2013826.","DOI":"10.1182\/blood-2002-05-1498"},{"key":"2019111702525579800_R9","doi-asserted-by":"crossref","unstructured":"Alter BP. Cancer in Fanconi anemia, 1927\u20132001. Cancer. 2003;97:425\u2013440.","DOI":"10.1002\/cncr.11046"},{"key":"2019111702525579800_R10","doi-asserted-by":"crossref","unstructured":"Rosenberg PS, Socie G, Alter BP, Gluckman E. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood. 2005;105:67\u201373.","DOI":"10.1182\/blood-2004-04-1652"},{"key":"2019111702525579800_R11","doi-asserted-by":"crossref","unstructured":"Tonnies H, Huber S, Kuhl J-S, et al. Clonal chromosome aberrations in bone marrow cells of Fanconi anemia patients: gains of the chromosomal segment 3q26q29 as an adverse risk factor. Blood. 2003;101:3872\u20133874.","DOI":"10.1182\/blood-2002-10-3243"},{"key":"2019111702525579800_R12","doi-asserted-by":"crossref","unstructured":"Alter BP, Joenje H, Oostra AB, Pals G. Fanconi anemia: adult head and neck cancer and hematopoietic mosaicism. Arch Otolaryngol Head Neck Surg. 2005;131:635\u2013639.","DOI":"10.1001\/archotol.131.7.635"},{"key":"2019111702525579800_R13","doi-asserted-by":"crossref","unstructured":"Taniguchi T, D\u2019Andrea AD. The molecular pathogenesis of fanconi anemia: recent progress. Blood. 2006;4223\u20134233.","DOI":"10.1182\/blood-2005-10-4240"},{"key":"2019111702525579800_R14","doi-asserted-by":"crossref","unstructured":"Bagby GC, Jr. Genetic basis of Fanconi anemia. Curr Opin Hematol. 2003;10:68\u201376.","DOI":"10.1097\/00062752-200301000-00011"},{"key":"2019111702525579800_R15","unstructured":"Jacquemont C, Taniguchi T. Disruption of the Fanconi anemia pathway in human cancer in the general population. Cancer Biol.Ther. 2006;5:1637\u20131639."},{"key":"2019111702525579800_R16","doi-asserted-by":"crossref","unstructured":"Rosenberg PS, Huang Z-G, Alter BP. Individualized risks of first adverse events in patients with Fanconi anemia. Blood. 2004;104:350\u2013355.","DOI":"10.1182\/blood-2004-01-0083"},{"key":"2019111702525579800_R17","unstructured":"Fanconi Anemia: Standards for Clinical Care. Eugene, OR: Fanconi Anemia Research Fund, Inc; 2003. Available at www.fanconi.org."},{"key":"2019111702525579800_R18","doi-asserted-by":"crossref","unstructured":"Alter BP. Radiosensitivity in Fanconi\u2019s anemia patients. Radiother Oncol. 2002;62:345\u2013347.","DOI":"10.1016\/S0167-8140(01)00474-1"},{"key":"2019111702525579800_R19","doi-asserted-by":"crossref","unstructured":"Vulliamy TJ, Marrone A, Knight SW, et al. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood. 2006;107:2680\u20132685.","DOI":"10.1182\/blood-2005-07-2622"},{"key":"2019111702525579800_R20","doi-asserted-by":"crossref","unstructured":"Alter BP, Baerlocher GM, Savage SA, et al. Very short telomere length by flow fluorescence in situ hybridization identifies patients with Dyskeratosis Congenita. Blood. 2007;110:1439\u20131447.","DOI":"10.1182\/blood-2007-02-075598"},{"key":"2019111702525579800_R21","doi-asserted-by":"crossref","unstructured":"Brummendorf TH, Maciejewski JP, Mak J, Young NS, Lansdorp PM. Telomere length in leukocyte subpopulations of patients with aplastic anemia. Blood. 2001;97:895\u2013900.","DOI":"10.1182\/blood.V97.4.895"},{"key":"2019111702525579800_R22","doi-asserted-by":"crossref","unstructured":"Walne AJ, Vulliamy T, Marrone A, et al. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet. 2007;16:1619\u20131629.","DOI":"10.1093\/hmg\/ddm111"},{"key":"2019111702525579800_R23","doi-asserted-by":"crossref","unstructured":"Lansdorp PM. Major cutbacks at chromosome ends. Trends Biochem Sci. 2005;30:388\u2013395.","DOI":"10.1016\/j.tibs.2005.05.004"},{"key":"2019111702525579800_R24","doi-asserted-by":"crossref","unstructured":"Fogarty PF, Yamaguchi H, Wiestner A, et al. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet. 2003;362:1628\u20131630.","DOI":"10.1016\/S0140-6736(03)14797-6"},{"key":"2019111702525579800_R25","doi-asserted-by":"crossref","unstructured":"Al-Rahawan MM, Giri N, Alter BP. Intensive immunosuppression therapy for aplastic anemia associated with dyskeratosis congenita. Int J Hematol. 2006;83:275\u2013276.","DOI":"10.1532\/IJH97.06030"},{"key":"2019111702525579800_R26","doi-asserted-by":"crossref","unstructured":"Giri N, Batista DL, Alter BP, Stratakis CA. Endocrine abnormalities in patients with Fanconi anemia. J Clin Endocrinol Metab. 2007;92:2624\u20132631.","DOI":"10.1210\/jc.2007-0135"},{"key":"2019111702525579800_R27","doi-asserted-by":"crossref","unstructured":"Flygare J, Aspesi A, Bailey JC, et al. Human RPS19, the gene mutated in Diamond-Blackfan anemia, encodes a ribosomal protein required for the maturation of 40S ribosomal subunits. Blood. 2007;109:980\u2013986.","DOI":"10.1182\/blood-2006-07-038232"},{"key":"2019111702525579800_R28","doi-asserted-by":"crossref","unstructured":"Flygare J, Karlsson S. Diamond-Blackfan anemia: erythropoiesis lost in translation. Blood. 2007;109:3152\u20133154.","DOI":"10.1182\/blood-2006-09-001222"},{"key":"2019111702525579800_R29","doi-asserted-by":"crossref","unstructured":"Ip WF, Dupuis A, Ellis L, et al. Serum pancreatic enzymes define the pancreatic phenotype in patients with Shwachman-Diamond syndrome. J Pediatr. 2002;141:259\u2013265.","DOI":"10.1067\/mpd.2002.125849"},{"key":"2019111702525579800_R30","doi-asserted-by":"crossref","unstructured":"Boocock GR, Morrison JA, Popovic M, et al. Mutations in SBDS are associated with Shwachman-Diamond syndrome. Nat Genet. 2003;33:97\u2013101.","DOI":"10.1038\/ng1062"},{"key":"2019111702525579800_R31","doi-asserted-by":"crossref","unstructured":"Austin KM, Leary RJ, Shimamura A. The Shwachman-Diamond SBDS protein localizes to the nucleolus. Blood. 2005;106:1253\u20131258.","DOI":"10.1182\/blood-2005-02-0807"},{"key":"2019111702525579800_R32","doi-asserted-by":"crossref","unstructured":"Person RE, Li F-Q, Duan Z, et al. Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2. Nat Genet. 2003;34:308\u2013312.","DOI":"10.1038\/ng1170"},{"key":"2019111702525579800_R33","doi-asserted-by":"crossref","unstructured":"Klein C, Grudzien M, Appaswamy G, et al. HAX1 deficiency causes autosomal recessive severe congenital neutropenia (Kostmann disease). Nat Genet. 2007;39:86\u201392.","DOI":"10.1038\/ng1940"},{"key":"2019111702525579800_R34","doi-asserted-by":"crossref","unstructured":"Horwitz MS, Duan Z, Korkmaz B, et al. Neutrophil elastase in cyclic and severe congenital neutropenia. Blood. 2007;109:1817\u20131824.","DOI":"10.1182\/blood-2006-08-019166"},{"key":"2019111702525579800_R35","doi-asserted-by":"crossref","unstructured":"Germeshausen M, Ballmaier M, Welte K. MPL mutations in 23 patients suffering from congenital amegakaryocytic thrombocytopenia: the type of mutation predicts the course of the disease. Hum Mutat. 2006;27:296\u2013301.","DOI":"10.1002\/humu.9415"},{"key":"2019111702525579800_R36","doi-asserted-by":"crossref","unstructured":"Klopocki E, Schulze H, Strauss G, et al. Complex inheritance pattern resembling autosomal recessive inheritance involving a microdeletion in thrombocytopenia-absent radius syndrome. Am J Hum Genet. 2007;80:232\u2013240.","DOI":"10.1086\/510919"},{"key":"2019111702525579800_R37","doi-asserted-by":"crossref","unstructured":"Grompe M, van de Vrogt H. The Fanconi family adds a fraternal twin. Dev Cell. 2007;12:661\u2013662.","DOI":"10.1016\/j.devcel.2007.04.008"},{"key":"2019111702525579800_R38","doi-asserted-by":"crossref","unstructured":"Hodes RJ, Hathcock KS, Weng N-P. Telomeres in T and B cells. Nat Rev Immunol. 2002;2:699\u2013706.","DOI":"10.1038\/nri890"}],"container-title":["Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2007\/1\/29\/646303\/029_039ash.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/hematology\/article-pdf\/2007\/1\/29\/646303\/029_039ash.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,17]],"date-time":"2019-11-17T02:53:13Z","timestamp":1573959193000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/hematology\/article\/2007\/1\/29\/19195\/Diagnosis-Genetics-and-Management-of-Inherited"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1,1]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1,1]]}},"URL":"https:\/\/doi.org\/10.1182\/asheducation-2007.1.29","relation":{},"ISSN":["1520-4391","1520-4383"],"issn-type":[{"value":"1520-4391","type":"print"},{"value":"1520-4383","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1,1]]}}}